Bausch Health Expands Dermatology Cash-Pay Prescription Program to Walgreens Stores Nationwide
01 Août 2019 - 1:00PM
Business Wire
Dermatology.com Supports Lower, Predictable
Pricing for Many of Bausch Health’s Prescription Dermatology
Products at Walgreens 9,500 Retail Pharmacies
Walgreens and Bausch Health Companies Inc. (NYSE/TSX: BHC)
("Bausch Health") today announced a modification to their existing
fulfillment agreement to bring patients lower prices, increased
transparency and convenience for many of Bausch Health’s
dermatology products. Under the expanded agreement, Walgreens
patients will have access to select dermatology products from
Bausch Health’s first-of-its-kind cash-pay prescription program,
Dermatology.com, at lower flat cash rates ranging from $50-$115.
The program was launched under its Ortho Dermatologics business in
March 2019, and will be available at more than 9,500 Walgreens U.S.
retail pharmacy locations by the end of August 2019.
“We launched dermatology.com to provide patients with direct
access to proven, branded dermatology medicines at predictable
prices,” said Bill Humphries, president, Ortho Dermatologics.
“Through this new expanded relationship with Walgreens, patients
using the program will now have a nationwide pharmacy option that
is not only welcoming and accessible, but will provide them with
the confidence that the cost they discuss with their physician will
be what they pay at the pharmacy. Together, we will continue to
strive to deliver on our commitment to provide the best possible
access and experience for patients who need these therapies.”
The suite of products included in the cash-pay prescription
program treat a range of dermatological conditions, including
actinic keratosis (AK), acne, barrier repair (e.g. eczema
treatments), and corticosteroid-responsive diseases. These disease
states typically encounter insurance coverage challenges and high
prescription costs. All products included in the program are also
eligible for Flexible Spending Accounts or Health Saving
Accounts.
“Walgreens is committed to providing solutions that advance
patient care and cost savings for our customers and the healthcare
system,” said Alex Gourlay, co-chief operating officer for
Walgreens Boots Alliance, Inc. “Through our collaboration with
Bausch Health, we are able to offer a set pricing model that
provides patients the security of knowing the cost of their
dermatology prescriptions each time they refill them at Walgreens,
while decreasing complexities and processes to allow our
pharmacists to focus on providing advice and support to
patients.”
About Ortho Dermatologics
Ortho Dermatologics is one of the largest prescription
dermatology businesses dedicated to helping patients in the
treatment of a range of therapeutic areas, including psoriasis,
actinic keratosis, acne, atopic dermatitis and other dermatoses.
The Ortho Dermatologics portfolio includes several leading acne,
anti-fungal and corticosteroid-responsive dermatoses products. More
information can be found at www.ortho-dermatologics.com.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company
whose mission is to improve people's lives with our health care
products. We develop, manufacture and market a range of
pharmaceutical, medical device and over-the-counter products,
primarily in the therapeutic areas of eye health, gastroenterology
and dermatology. We are delivering on our commitments as we build
an innovative company dedicated to advancing global health. More
information can be found at www.bauschhealth.com.
About Walgreens
Walgreens (walgreens.com), one of the nation's largest drugstore
chains, is included in the Retail Pharmacy USA Division of
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global
pharmacy-led, health and wellbeing enterprise. Approximately 8
million customers interact with Walgreens in stores and online each
day, using the most convenient, multichannel access to consumer
goods and services and trusted, cost-effective pharmacy, health and
wellness services and advice. As of August 31, 2018, Walgreens
operates 9,560 drugstores with a presence in all 50 states, the
District of Columbia, Puerto Rico and the U.S. Virgin Islands,
along with its omnichannel business, Walgreens.com. Approximately
400 Walgreens stores offer Healthcare Clinic or other provider
retail clinic services.
Forward-Looking Statements
All statements in this release that are not historical are
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are not guarantees of future
performance and involve risks, assumptions and uncertainties,
including, but not limited to, those related to the timing and
effectiveness of collaboration plans, the ability to realize the
anticipated benefits of the collaboration, competitive actions in
the marketplace, and the ability to achieve anticipated financial
and operating results in the amounts and at the times anticipated,
as well as those described in Item 1A (Risk Factors) of Walgreens
Boots Alliance, Inc.’s Form 10-K for its fiscal year ended August
31, 2018 and Form 10-Q for its fiscal quarter ended February 28,
2019, Bausch Health’s Form 10-K for its fiscal year ended December
31, 2018, and subsequent documents that Walgreens Boots Alliance,
Inc. and Bausch Health file or furnish with the Securities and
Exchange Commission. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially. These
forward-looking statements speak only as of the date they are made.
Except to the extent required by law, each of Walgreens Boots
Alliance, Inc., Walgreens and Bausch Health do not undertake, and
expressly disclaim, any duty or obligation to update publicly any
forward-looking statement after the date of this release, whether
as a result of new information, future events, changes in
assumptions or otherwise.
All product/brand names and or logos are trademarks of the
respective owners. © 2019 Bausch Health Companies Inc. or its
affiliates. NPR.0158.USA.19
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190801005173/en/
Walgreens Contact: Kelli Teno 224-237-4526
kelli.teno@walgreens.com
Bausch Health Contact: Arthur Shannon 514-856-3855
877-281-6642 (toll free) arthur.shannon@bauschhealth.com
Walgreens Boots Alliance (NASDAQ:WBA)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Walgreens Boots Alliance (NASDAQ:WBA)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024